Losartan Potassium Tablet, Film Coated
Product Images NDC 50090-4712

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-4712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losartanstructure (Losartanstructure)

Losartanstructure (Losartanstructure)
Chemical structure of Losartan Potassium showing its molecular arrangement including rings and functional groups as part of the active ingredient in the product.*
FDA Label Image

Losartanfigure1 (Losartanfigure1)

Losartanfigure1 (Losartanfigure1)
A line graph comparing the percentage of patients with a primary endpoint over a 60-month study period for Losartan Potassium versus Atenolol. The graph shows a steady increase in events for both drugs, with Losartan Potassium having a lower cumulative percentage. The chart includes an adjusted risk reduction of 13% with a p-value of 0.021.*
FDA Label Image

Losartanfigure2 (Losartanfigure2)

Losartanfigure2 (Losartanfigure2)
A line graph comparing the percentage of patients with fatal or non-fatal stroke over time (up to approximately 66 study months) between two treatments: Losartan Potassium and Atenolol. The graph includes a note indicating an adjusted risk reduction of 25% with p=0.001 favoring Losartan Potassium.*
FDA Label Image

Losartanfigure3 (Losartanfigure3)

Losartanfigure3 (Losartanfigure3)
A figure titled 'Primary Endpoint Events within Demographic Subgroups' showing hazard ratios with 95% confidence intervals for Losartan Potassium and Atenolol events in primary composite and stroke (fatal/non-fatal) categories across patient subgroups by age, gender, race, ISH, diabetes, and history of cardiovascular disease. The chart compares event rates and favors either Losartan Potassium or Atenolol.*
FDA Label Image

Losartanfigure4 (Losartanfigure4)

Losartanfigure4 (Losartanfigure4)
A line graph comparing the percentage of patients experiencing an event over 48 months between Losartan potassium and placebo groups. The vertical axis shows percent of patients with event, and the horizontal axis shows time in months, with Losartan potassium resulting in fewer events compared to placebo.*
FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Label Image (Lbl500904712)

Label Image (Lbl500904712)
Losartan Potassium 100 mg film-coated tablets label from A-S Medication Solutions. The label includes product number 6297-0 and NDC 50090-4712. Storage instructions specify keeping at 68 to 77 degrees Fahrenheit and protecting from light. The package contains 90 tablets and provides a QR code linking to the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.